PsilodexMedication × psilocybin
Your list , 0 items
Medication class

Migraine medications and psilocybin.

21 records in this group. None has published human data with psilocybin or another classic psychedelic; the rest draw on each medication's own pharmacology and label. State rules are summarized for Colorado, Oregon and New Mexico.

21Records
0With human data

Also searched as migraine medication · triptan · triptans · CGRP · migraine

01 What the evidence covers

Best evidence available per medication
21No psilocybin data
No psilocybin data: no human data with psilocybin or another classic psychedelic; the text draws on the medication's own pharmacology and its label or reference facts

02 Each medication

A to Z
  • Acetaminophen–aspirin–caffeine · Excedrin Extra Strength, Excedrin MigraineEvidence: No psilocybin data

    Minor aches and pains (headache, colds, arthritis, muscular aches, toothache, menstrual cramps); Migraine

    Its caffeine may add to psilocybin's brief rise in heart rate. Acetaminophen and aspirin are not studied with psilocybin.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • AlmotriptanEvidence: No psilocybin data

    Migraine attacks (acute treatment, adults); Migraine headache pain in adolescents 12 to 17 (acute treatment)

    It may add to psilocybin's serotonin activity and brief blood pressure rise. Also, its label reports rare significant blood pressure elevation.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Atogepant · QuliptaEvidence: No psilocybin data

    Migraine prevention

    Not studied with psilocybin; its label reports new or worsened high blood pressure, which may add to psilocybin's brief blood pressure rise.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Dihydroergotamine · D.H.E. 45, Trudhesa, MigranalEvidence: No psilocybin data

    Migraine attacks (acute treatment); Cluster headache episodes (acute treatment, injection)

    It narrows blood vessels and has rarely raised blood pressure, which may add to psilocybin's rise. Also, uncontrolled high blood pressure is a label contraindication.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Eletriptan · RelpaxEvidence: No psilocybin data

    Migraine attacks (acute treatment)

    It may add to psilocybin's serotonin effects and blood pressure rise (not studied with psilocybin). Also, it narrows blood vessels and rarely spikes blood pressure.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Eptinezumab · VyeptiEvidence: No psilocybin data

    Migraine prevention (adults)

    Not studied with psilocybin; no linking mechanism is described. Its label reports new or worse high blood pressure, which psilocybin also briefly raises.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Erenumab · AimovigEvidence: No psilocybin data

    Migraine prevention

    Not studied with psilocybin. Also, its label reports high blood pressure, most often within a week of a dose, and constipation.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Ergotamine · Cafergot, ErgomarEvidence: No psilocybin data

    Migraine and other vascular headaches (to stop or prevent attacks); Cluster headache (histaminic cephalalgia)

    It may add to psilocybin's blood pressure rise, since it strongly narrows blood vessels; it also acts on serotonin receptors.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Fremanezumab · AjovyEvidence: No psilocybin data

    Migraine prevention (adults); Episodic migraine prevention (age 6 to 17, weight 45 kg or more)

    Not studied with psilocybin; no linking mechanism is described. Its label reports new or worse high blood pressure, which psilocybin also briefly raises.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • FrovatriptanEvidence: No psilocybin data

    Migraine attacks (acute treatment)

    It may add to psilocybin's serotonin effects and blood pressure rise (not studied with psilocybin); a dose from the day before may linger.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Galcanezumab · EmgalityEvidence: No psilocybin data

    Migraine prevention (adults); Episodic cluster headache (adults)

    Not studied with psilocybin; no linking mechanism is described. Its label reports new or worse high blood pressure, which psilocybin also briefly raises.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Lasmiditan · ReyvowEvidence: No psilocybin data

    Migraine attacks (acute treatment, with or without aura)

    Its label reports hallucinations and euphoria, which may add to psilocybin's effects, and it causes sleepiness and dizziness.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Meloxicam–rizatriptan · SymbravoEvidence: No psilocybin data

    Migraine attacks (acute treatment)

    Not studied with psilocybin; both parts can raise blood pressure and one acts on serotonin, so added effects are possible.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Naratriptan · AmergeEvidence: No psilocybin data

    Migraine attacks, with or without aura (acute treatment in adults)

    It narrows blood vessels and acts on serotonin, so it may add to psilocybin's effects and blood pressure rise.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Rimegepant · Nurtec ODTEvidence: No psilocybin data

    Migraine attacks (acute treatment); Prevention of episodic migraine

    Not studied with psilocybin; no linking mechanism is described; its label reports raised blood pressure, which may add to psilocybin's rise.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Rizatriptan · MaxaltEvidence: No psilocybin data

    Migraine attacks (acute treatment, adults and children 6 and older)

    It may add to psilocybin's serotonin effects and blood pressure rise (not studied). Also, its label reports rare significant blood pressure elevation.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Sumatriptan · ImitrexEvidence: No psilocybin data

    Migraine attacks (acute treatment); Cluster headache attacks (acute treatment, injection)

    Its serotonin activity may add to psilocybin's effects and blood pressure rise. Also, its label reports rare significant blood pressure rises.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Sumatriptan–naproxen · TreximetEvidence: No psilocybin data

    Acute treatment of migraine with or without aura (adults and children 12 and older)

    Sumatriptan's serotonin activity may add to psilocybin's effects and brief blood pressure rise. Also, its label reports rare significant blood pressure rises.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Ubrogepant · UbrelvyEvidence: No psilocybin data

    Migraine attacks (acute treatment)

    Not studied with psilocybin; no linking mechanism is described; its label reports raised blood pressure, which may add to psilocybin's brief rise.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Zavegepant · ZavzpretEvidence: No psilocybin data

    Migraine attacks (acute treatment)

    Not studied with psilocybin; no linking mechanism is described. Its label reports new or worse high blood pressure; psilocybin also briefly raises blood pressure.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Zolmitriptan · ZomigEvidence: No psilocybin data

    Migraine attacks (acute treatment)

    Its serotonin activity may add to psilocybin's effects and blood pressure rise.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

03 Properties the records flag

Records with each flag
20Raises blood pressure or heart rate
12Serotonergic
2Liver injury
2Lowers seizure threshold or carries seizure risk
1Psychiatric reactions
1Sedating or CNS depressant
1Withdrawal or rebound if stopped abruptly

Flags describe a medication's own properties, each cited in its record. A flag is not a finding about any combination. Definitions are on the Method page.

04 State rules

Official text governs
COColorado · final · checked 2026-10-24

No provision names these medications or this group.

OROregon · final · checked 2026-10-24

No provision names these medications or this group.

NMNew Mexico · pending · checked 2026-10-24

Rules not final; the proposed rules reviewed name no medication in this group.

05 Studies cited in this group

Records citing each
14Halman A, Kong G, Sarris J, Perkins D. Drug–drug interactions involving classic psychedelics: a systematic review. J Psychopharmacol 2024;38(1):3–18.
14Sarparast A, Thomas K, Malcolm B, Stauffer CS. Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology 2022;239(6):1945–1976.
2Thomann J, Kolaczynska KE, Stoeckmann OV, et al. In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin. Front Pharmacol 2024;15:1391689.

Related classes

Records reviewed 2026-10-03 to 2026-10-04. Each row summarizes one record; the full record, with every source, opens in the browser and is not sent to the server. All classes · Browse A–Z

AgreementPsilodex

Before you use Psilodex

Check each box to continue.

Your searches, your list and the medications you look up stay in this browser. We can't see them. Privacy · Emergency: 911 · Mental health crisis: call or text 988 · Poison Control: 1-800-222-1222

Terms version 2026-10-25